【结 构 式】 |
【药物名称】Emedastine difumarate, Emedastine fumarate, AL-3432A, KG-2413, LY-188695, KB-2413, Emadine(as ophthalmic formulation), Rapimine, Remicut, Daren 【化学名称】1-(2-Ethoxyethyl)-2-(4-methyl-hexahydro-1H-1,4-diazepin-1-yl)-1H-benzimidazole (E)-2-butenedioate (1:2) 【CA登记号】87233-62-3, 87233-76-9 ((2:3) salt), 87233-61-2 (free base) 【 分 子 式 】C25H34N4O9 【 分 子 量 】534.57113 |
【开发单位】Kanebo (Originator), Alcon (Licensee), Kowa (Licensee) 【药理作用】Allergic Skin Disorders, Treatment for, Antiallergic Ophthalmic Agents, DERMATOLOGIC DRUGS, Drugs for Allergic Rhinitis, Ocular Antiinflammatory and Antiinfective Agents, OCULAR MEDICATIONS, Ophthalmic Drugs, RESPIRATORY DRUGS, Treatment of Upper Respiratory Tract Disorders, Urticaria, Treatment for, Histamine H1 Antagonists |
合成路线1
A new synthesis of KB-2413 has been described: The reaction of 2-chloronitrobenzene (I) with 2-ethoxyethylamine (II) gives 1-(2-ethoxyethylamino)-2-nitrobenzene (III), which is reduced with Zn and NaOH to N-(2-ethoxyethyl-o-phenylenediamine (IV). The cyclization of (IV) with urea in amyl alcohol affords 1-(2-ethoxyethyl)benzimidazol-2-one (V), which is treated with refluxing POCl3 yielding 2-chloro-1-(2-ethoxyethyl)benzimidazole (VI). Finally, this compound is condensed with N-methylhexahydro-1,4-diazepine (VII) and treated with fumaric acid.
【1】 Awata, N.; Satomi, O.; Synthesis of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-[2-14C]benzimidazole difumarate ([14C]KB-2413). J Label Compd Radiopharm 1987, 24, 3, 331-8. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 15248 | 1-chloro-2-nitrobenzene | 88-73-3 | C6H4ClNO2 | 详情 | 详情 |
(II) | 20898 | 2-ethoxyethylamine; 2-ethoxy-1-ethanamine | 110-76-9 | C4H11NO | 详情 | 详情 |
(III) | 20899 | N-(2-ethoxyethyl)-N-(2-nitrophenyl)amine; N-(2-ethoxyethyl)-2-nitroaniline | C10H14N2O3 | 详情 | 详情 | |
(IV) | 20900 | N(1)-(2-ethoxyethyl)-1,2-benzenediamine; N-(2-aminophenyl)-N-(2-ethoxyethyl)amine | C10H16N2O | 详情 | 详情 | |
(V) | 20901 | 1-(2-ethoxyethyl)-1,3-dihydro-2H-benzimidazol-2-one | C11H14N2O2 | 详情 | 详情 | |
(VI) | 20902 | 2-chloro-1-(2-ethoxyethyl)-1H-benzimidazole; 2-(2-chloro-1H-benzimidazol-1-yl)ethyl ethyl ether | C11H13ClN2O | 详情 | 详情 | |
(VII) | 20903 | 1-methyl-1,4-diazepane | 4318-37-0 | C6H14N2 | 详情 | 详情 |
合成路线2
The reaction of 2-chlorobenzimidazole (I) with 2-chloroethyl ethyl ether (II) by means of NaOH in DMF gives 1-(2-ethoxyethyl)benzimidazole (III), which is then condensed with N-methylhomopiperazine (IV) at 120 C.
【1】 Iemura, R.; et al. (Kanebo Pharmaceuticals, Ltd.); Benzimidazole derivatives, process for the peparation thereof and pharmaceutical composition containing the same. EP 0079545; JP 58079983 . |
【2】 Serradell, M.N.; Castaner, J.; KB-2413. Drugs Fut 1985, 10, 5, 397. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26761 | 2-chloroimidazo[1,2-a]pyridine; 2-chlorobenzimidazole; 2-Amino-4'-chlorodiphenylether; 2-Aminodiphenylether; 2-chloro-1H-benzimidazole | 4857-06-1 | C7H5ClN2 | 详情 | 详情 |
(II) | 29358 | 1-chloro-2-ethoxyethane | 628-34-2 | C4H9ClO | 详情 | 详情 |
(III) | 20902 | 2-chloro-1-(2-ethoxyethyl)-1H-benzimidazole; 2-(2-chloro-1H-benzimidazol-1-yl)ethyl ethyl ether | C11H13ClN2O | 详情 | 详情 | |
(IV) | 20903 | 1-methyl-1,4-diazepane | 4318-37-0 | C6H14N2 | 详情 | 详情 |